86 related articles for article (PubMed ID: 3166339)
1. T(8;21) with a phenotype of chronic myeloid leukemia.
Raskind WH; Papayannopoulou T; Hammond WP
Am J Hematol; 1988 Aug; 28(4):266-9. PubMed ID: 3166339
[TBL] [Abstract][Full Text] [Related]
2. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.
Shtalrid M; Talpaz M; Blick M; Romero P; Kantarjian H; Taylor K; Trujillo J; Schachner J; Gutterman JU; Kurzrock R
J Clin Oncol; 1988 Oct; 6(10):1569-75. PubMed ID: 3171624
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia.
Ohyashiki JH; Ohyashiki K; Ito H; Toyama K
Cancer Genet Cytogenet; 1988 Jul; 33(1):119-26. PubMed ID: 2838155
[TBL] [Abstract][Full Text] [Related]
4. Transposition of breakpoint cluster region (3' bcr) in CML cells with variant Philadelphia translocations.
Ohyashiki K; Ohyashiki JH; Kinniburgh AJ; Rowe J; Miller KB; Raza A; Preisler HD; Sandberg AA
Cancer Genet Cytogenet; 1987 May; 26(1):105-15. PubMed ID: 3030534
[TBL] [Abstract][Full Text] [Related]
5. DNA cytophotometry of chromosomes in a case of chronic myelogenous leukemia.
Mayall BH; Carrano AV; Rowley JD
Clin Chem; 1974 Aug; 20(8):1080-5. PubMed ID: 4136647
[No Abstract] [Full Text] [Related]
6. [Detection of bcr gene rearrangement in chronic myeloid leukemia by fluorescence in situ hybridization].
Liu M; Liu X; Niu C; He K; Su X; Cao Q; Chen L; Chen S
Zhonghua Xue Ye Xue Za Zhi; 1997 Jun; 18(6):308-10. PubMed ID: 15622626
[TBL] [Abstract][Full Text] [Related]
7. Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia.
Benn P; Soper L; Eisenberg A; Silver RT; Coleman M; Cacciapaglia B; Bennett L; Baird M; Silverstein M; Berger C
Cancer Genet Cytogenet; 1987 Nov; 29(1):1-7. PubMed ID: 2822224
[TBL] [Abstract][Full Text] [Related]
8. [BCR and ABL gene rearrangement in chronic myeloid leukemia].
Rypácková B; Haskovec C; Brdicka R
Vnitr Lek; 1993 Oct; 39(10):964-8. PubMed ID: 8236869
[TBL] [Abstract][Full Text] [Related]
9. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
11. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.
Andersson BS; Collins VP; Kurzrock R; Larkin DW; Childs C; Ost A; Cork A; Trujillo JM; Freireich EJ; Siciliano MJ
Leukemia; 1995 Dec; 9(12):2100-8. PubMed ID: 8609723
[TBL] [Abstract][Full Text] [Related]
12. Localization of c-Ha-ras-1 oncogene in the t(7p-;11p+) abnormality of two cases with myeloid leukemia.
Mise K; Abe S; Sato Y; Miura Y; Sasaki M
Cancer Genet Cytogenet; 1987 Dec; 29(2):191-9. PubMed ID: 3315181
[TBL] [Abstract][Full Text] [Related]
13. [Abnormality of chromosome number 1 in 3 cases of acute transformation of chronic myeloid leukemia].
Smadja N; Krulik M; Génot JY; Audebert AA; Debray J
Nouv Rev Fr Hematol (1978); 1984; 26(5):303-8. PubMed ID: 6594670
[TBL] [Abstract][Full Text] [Related]
14. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
15. Historical communication: Philadelphia-positive chronic myelogenous leukemia followed for 27 years.
Nowell PC; Jackson L; Weiss A; Kurzrock R
Cancer Genet Cytogenet; 1988 Aug; 34(1):57-61. PubMed ID: 3165050
[TBL] [Abstract][Full Text] [Related]
16. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
17. Molecular lesion in chronic granulocytic leukemia is highly conserved despite ethnic and geographical variation.
Chan LC; Chen PM; Powles R; Saragas E; Wiedemann LM; Groffen J; Greaves MF
Leukemia; 1987 Jun; 1(6):486-90. PubMed ID: 2823024
[TBL] [Abstract][Full Text] [Related]
18. Complex cytogenetic changes in Ph-negative chronic myelogenous leukemia.
Wang TY; Raza A; Fan YS; Sait SN; Kirschner J; Sandberg AA
Cancer Genet Cytogenet; 1988 Apr; 31(2):241-5. PubMed ID: 3162397
[TBL] [Abstract][Full Text] [Related]
19. [Significance of cytogenetic studies in chronic granulocytic leukemia].
Oláh E; Kiss A; Jákó J
Orv Hetil; 1980 Aug; 121(32):1933-9. PubMed ID: 6935618
[No Abstract] [Full Text] [Related]
20. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
